European Pharmacy & Wellness Products in the USA

Milgamma® 300 mg by Wörwag Pharma is a German medicinal product containing a high-dose combination of benfotiamine, a lipid-soluble derivative of vitamin B1, and pyridoxine hydrochloride (vitamin B6).

Its official German indication is the treatment of neurological systemic disorders caused by a confirmed deficiency of vitamins B1 and B6.

Vitamin B1 and vitamin B6 are important for normal nerve function and cellular energy metabolism. Benfotiamine is a lipid-soluble vitamin B1 derivative used in Milgamma to improve the supply of vitamin B1 to nerve cells.

Each package contains 30 film-coated tablets.

Active Ingredients

Each film-coated tablet contains:

The 100 mg of pyridoxine hydrochloride corresponds to approximately 82.27 mg pyridoxine.

Indication

Milgamma 300 mg is officially indicated for:

Neurological systemic diseases caused by a diagnosed deficiency of vitamins B1 and B6.

This distinction is important for the Shopify page: Milgamma 300 should not be presented as a general vitamin supplement or as a treatment for every type of neuropathy. Its medicinal indication specifically relates to neurological disease associated with confirmed B1/B6 deficiency.

Key Features

• High-dose Vitamin B1 + B6 medicinal combination
• 300 mg benfotiamine per tablet
• 100 mg pyridoxine hydrochloride (Vitamin B6) per tablet
• Supports adequate vitamin supply to nerve cells
• Intended for neurological disorders associated with confirmed B1/B6 deficiency
• Benfotiamine is a lipid-soluble derivative of vitamin B1
• Gluten-free
• Lactose-free
• Scored film-coated tablets
• German pharmacy medicine
• 30 tablets per package

Other Ingredients

Microcrystalline cellulose, powdered cellulose, corn starch, gelatin, magnesium stearate, hypromellose, propylene glycol, titanium dioxide, iron(III) hydroxide oxide, talc, and macrogol 6000.

How to Use

Unless otherwise prescribed, adults take 1 tablet once daily with sufficient liquid.

In acute cases, after consultation with a physician, the dosage may be increased to 1 tablet three times daily.

After no more than 4 weeks, a physician should determine whether the higher dosage remains necessary. If appropriate, the dose should be reduced to once daily to decrease the risk of neuropathy associated with prolonged high-dose vitamin B6 exposure.

Important Information

• This is a medicinal product, not a standard daily multivitamin.
• The product contains a high dose of vitamin B6.
• Long-term use of high doses of vitamin B6 can itself cause peripheral sensory neuropathy; prolonged treatment should therefore be medically supervised.
• Consult a physician or pharmacist if symptoms persist, worsen, or their cause has not been established.
• Consult a healthcare professional before use during pregnancy or breastfeeding.
• Do not use if allergic to benfotiamine, pyridoxine hydrochloride, or another ingredient.
• Read the package leaflet before use.

Storage

Store below 25°C and protect from light. Keep out of reach of children.

Product Details

Brand: Milgamma®
Product: Milgamma® 300 mg
Active Ingredients: Benfotiamine + Pyridoxine Hydrochloride
Strength: 300 mg + 100 mg per tablet
Form: Film-Coated Tablets
Package Size: 30 Tablets
PZN: 02913880
Manufacturer: Wörwag Pharma GmbH & Co. KG
Country of Origin: Germany
German Status: Non-Prescription, Pharmacy-Only Medicinal Product

Important Product Distinction

Milgamma 300 mg is not the same as Milgamma Protekt 300 mg.

Milgamma 300 mg contains 300 mg benfotiamine + 100 mg vitamin B6, whereas Milgamma Protekt 300 mgcontains 300 mg benfotiamine only.